価格表

在庫・価格 : 2024年05月07日 12時30分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Aurora A, Mouse-Mono(35C1)
データシート
GTX13824 GNTジーンテックス
GeneTex International Corporation
50 μg ¥81,000
(未発注)
追加

在庫・価格 : 2024年05月07日 12時30分 現在

Anti-Aurora A, Mouse-Mono(35C1)

  • 商品コード:GTX13824
  • メーカー:GNT
  • 包装:50μg
  • 価格: ¥81,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yang G et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin. Cancer Res. 2010 Jun;16(12):3171-81
Yang G et al
2010/01/01
PubMed
2 Pakala SB et al. Signaling-dependent phosphorylation of mitotic centromere-associated kinesin regulates microtubule depolymerization and its centrosomal localization. J. Biol. Chem. 2012 Nov;287(48):40560-9
Pakala SB et al
2012/01/01
PubMed
3 Yang G et al. RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis. Int. J. Cancer 2013 Jul;133(2):275-85
Yang G et al
2013/01/01
Application: ICC/IF, WB, Reactivity: Hu PubMed
4 Chen YP et al. CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors. Int. J. Cancer 2014 Aug;135(3):751-62
Chen YP et al
2014/01/01
Application: Western blot, Reactivity: Human PubMed
5 Goldenson B et al. Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation. Blood 2015 Mar;125(13):2141-50
Goldenson B et al
2015/01/01
PubMed
6 Chang KC et al. Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma. PLoS ONE 2013;8(11):e79863
Chang KC et al
2013/01/01
PubMed
7 Yang F et al. AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma. Mod. Pathol. 2011 Jun;24(6):836-45
Yang F et al
2011/01/01
PubMed
8 Richards MW et al. Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2016 Nov;113(48):13726-13731
Richards MW et al
2016/01/01
PubMed
9 Wen QJ et al. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat. Med. 2015 Dec;21(12):1473-80
Wen QJ et al
2015/01/01
Application: Western Blot (WB), Reactivity: Mouse PubMed
10 Wang YC et al. The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes. Exp. Mol. Med. 2018 Jun;50(6):70
Wang YC et al
2018/01/01
Application: IHC (Formalin-fixed paraffin-embedded sections), Reactivity: Human PubMed
11 Aradottir M et al. Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers. J Pathol Clin Res 2015 Jan;1(1):33-40
Aradottir M et al
2015/01/01
Application: IHC (Formalin-fixed paraffin-embedded sections), Reactivity: Human PubMed
12 Lai CH et al. A selective Aurora-A 5"-UTR siRNA inhibits tumor growth and metastasis. Cancer Lett. 2020 03;472:97-107
Lai CH et al
2020/01/01
PubMed
13 Margret Aradottir et al., Margret Aradottir, The Journal of Pathology: Clinical Research, 2014

PubMed
14 P辿rez-Fidalgo JA et al. Aurora kinases in ovarian cancer. ESMO Open 2020 10;5(5):e000718
P辿rez-Fidalgo JA et al
2020/01/01
PubMed
  • No.: 1
  • 文献情報:
    Yang G et al. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin. Cancer Res. 2010 Jun;16(12):3171-81
    Yang G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Pakala SB et al. Signaling-dependent phosphorylation of mitotic centromere-associated kinesin regulates microtubule depolymerization and its centrosomal localization. J. Biol. Chem. 2012 Nov;287(48):40560-9
    Pakala SB et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Yang G et al. RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis. Int. J. Cancer 2013 Jul;133(2):275-85
    Yang G et al
    2013/01/01
  • 備考:
    Application: ICC/IF, WB, Reactivity: Hu
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Chen YP et al. CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors. Int. J. Cancer 2014 Aug;135(3):751-62
    Chen YP et al
    2014/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Goldenson B et al. Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation. Blood 2015 Mar;125(13):2141-50
    Goldenson B et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Chang KC et al. Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma. PLoS ONE 2013;8(11):e79863
    Chang KC et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yang F et al. AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma. Mod. Pathol. 2011 Jun;24(6):836-45
    Yang F et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Richards MW et al. Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 2016 Nov;113(48):13726-13731
    Richards MW et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wen QJ et al. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat. Med. 2015 Dec;21(12):1473-80
    Wen QJ et al
    2015/01/01
  • 備考:
    Application: Western Blot (WB), Reactivity: Mouse
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Wang YC et al. The EGF/hnRNP Q1 axis is involved in tumorigenesis via the regulation of cell cycle-related genes. Exp. Mol. Med. 2018 Jun;50(6):70
    Wang YC et al
    2018/01/01
  • 備考:
    Application: IHC (Formalin-fixed paraffin-embedded sections), Reactivity: Human
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Aradottir M et al. Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers. J Pathol Clin Res 2015 Jan;1(1):33-40
    Aradottir M et al
    2015/01/01
  • 備考:
    Application: IHC (Formalin-fixed paraffin-embedded sections), Reactivity: Human
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Lai CH et al. A selective Aurora-A 5"-UTR siRNA inhibits tumor growth and metastasis. Cancer Lett. 2020 03;472:97-107
    Lai CH et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Margret Aradottir et al., Margret Aradottir, The Journal of Pathology: Clinical Research, 2014

  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    P辿rez-Fidalgo JA et al. Aurora kinases in ovarian cancer. ESMO Open 2020 10;5(5):e000718
    P辿rez-Fidalgo JA et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed